- Cannabics Pharmaceuticals (OTCQB:CNBX) announces that it has filed a patent application under the Patent Cooperation Treaty (PCT) for novel formulations developed for treatment of various cancer types.
- The patent application includes preclinical supporting data collected from in-vitro experiments performed in the company's in-house drug discovery facilities in Israel, as well as from in-vivo experiments performed on mice, Cannabics said.
Cannabics files a PCT patent application for proprietary cancer treatment formulations
Recommended For You
More Trending News
About CNBX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CNBX | - | - |
CNBX Pharmaceuticals Inc. |